Tompkins Financial Corp Decreases Stake in Chemed Co. (NYSE:CHE)

Tompkins Financial Corp cut its position in Chemed Co. (NYSE:CHE) by 43.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 174 shares of the company’s stock after selling 136 shares during the period. Tompkins Financial Corp’s holdings in Chemed were worth $92,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. American National Bank & Trust acquired a new position in shares of Chemed during the third quarter worth $61,000. GAMMA Investing LLC lifted its holdings in Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after buying an additional 52 shares during the last quarter. Quarry LP boosted its position in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after acquiring an additional 166 shares in the last quarter. Sound Income Strategies LLC purchased a new position in shares of Chemed in the 3rd quarter valued at about $201,000. Finally, Farther Finance Advisors LLC raised its position in shares of Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after acquiring an additional 324 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Up 0.4 %

Shares of NYSE CHE opened at $555.01 on Friday. The business has a 50-day moving average price of $545.31 and a 200 day moving average price of $562.50. The stock has a market cap of $8.35 billion, a PE ratio of 28.04, a price-to-earnings-growth ratio of 2.04 and a beta of 0.47. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $5.32 earnings per share. Sell-side analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed’s dividend payout ratio is presently 10.11%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CHE. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada dropped their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.